Articles Referencing IDIX
Idenix Pharma Initiates Phase II Study - Analyst Blog
5/31/2013, 6:30 pm from Zacks.com in Investing, Business, Stocks
Idenix Pharmaceuticals, Inc. ( IDIX ) recently
announced that it has initiated a phase II study (HELIX-1: n = 90)
evaluating the combination of hepatitis C virus (HCV) infection
candidates,... Read >>
The Far-Off Four, 52-week Lows Held by Gurus
5/11/2013, 2:42 pm from GuruFocus in Investing
This week the GuruFocus 52-week low screener reveals the "Far-Off
Four," meaning four stocks that are the farthest off-high: ANV
Allied Nevada Gold Corp ( ANV ) is at a... Read >>
Wealthtrack - Searching For Good Dividend Stocks
5/11/2013, 9:14 am from GuruFocus in Investing
Learn why all dividends are not created equal. Robert Shearer,
lead portfolio manager for BlackRock's Equity Dividend Fund
explains why some dividends are better than others and where he... Read >>
IDIX at 52-Week Low - Gurus Cohen, Klarman Holding On
4/3/2013, 7:05 pm from GuruFocus in Investing
The GuruFocus 52-week low screener reveals that Idenix
Pharmaceuticals ( IDIX ) is at a 52-week
low, with a low price of $3.32 (73.7% off its $12.61 high). Two
Guru investors Steven Cohen ... Read >>
Seth Klarman - IDIX Mega Shares and New FDA 'Breakthrough' Track
3/29/2013, 6:25 pm from GuruFocus in Investing
As of Feb. 9, 2013, Guru Seth Klarman , legendary value investor of The
Baupost Group, added 49.69% to his Idenix Pharmaceuticals Inc. ( IDIX ) mega position
currently at 24,740,200 shares.... Read >>
Setback for Idenix Pharma - Analyst Blog
3/28/2013, 6:24 pm from Zacks.com in Investing, Business, Stocks
Idenix Pharmaceuticals, Inc. ( IDIX ) recently
suffered a setback when the US Patent and Trademark Office Patent
Trial and Appeal Board (USPTO) issued a verdict against it in the
first... Read >>
Mid-Day Market Update: Markets Turn Red, Apollo Group Surges On Upbeat Results
3/25/2013, 1:11 pm from Benzinga in Investing, Commodities, Economy, International
Midway through trading Monday, the Dow traded down 0.41 percent
to 14,453.18 while the NASDAQ dropped 0.37 percent to 3,233.06. The
S&P also fell, dropping 0.30 percent to 1,552.26. ... Read >>
Mid-Morning Market Update: Markets Rise On Cyprus Deal, Dollar General Posts Higher Profit
3/25/2013, 11:03 am from Benzinga in Investing, Commodities, Economy, International
Following the market opening Monday, the Dow traded up 0.31
percent to 14,556.33 while the NASDAQ gained 0.41 percent to
3,258.20. The S&P also rose, gaining 0.47 percent to
1,564.17. ... Read >>
Idenix Reports In-Line 4Q Loss - Analyst Blog
3/1/2013, 10:08 am from Zacks.com in Investing, Business, Stocks
Idenix Pharmaceuticals' ( IDIX ) loss of 17
cents per share in the fourth quarter of 2012 was a penny below the
year-ago loss and in-line with the Zacks Consensus Estimate. The company's... Read >>
Pipeline Setback for Idenix - Analyst Blog
2/7/2013, 5:10 pm from Zacks.com in Investing, Business, Stocks
Idenix Pharmaceuticals, Inc. ( IDIX ) recently
announced that the company has decided to discontinue its clinical
development program for IDX184.
IDX184 is a nucleotide polymerase... Read >>
Mid-Afternoon Market Update: Markets Mixed, Herbalife Falld on FTC Attack on Fortune High Tech Marketing
1/28/2013, 3:22 pm from Benzinga in Investing, Commodities, Economy, International
Toward the end of trading Monday, the Dow traded up 0.03 percent
to 13,899.13 while the NASDAQ rose 0.29 percent to 3,158.63. The
S&P fell however, decreasing 0.05 percent to 1,502.25. ... Read >>
Mid-Day Market Update: Zynga Rides Positive Social Media Sentiment, Jos. A Bank Falls on Bad Guidance
1/28/2013, 1:15 pm from Benzinga in Investing, Commodities, Economy, International
Mid-way through trading Monday, the Dow traded down 0.10 percent
to 13,881.13 while the NASDAQ rose 0.18 percent to 3,155.63. The
S&P also fell, decreasing 0.15 percent to 1,500.25. ... Read >>
Seth Klarman Buys Rovi Corp, Novagold, Idenix Pharmaceuticals, Sells Hewlett-packard, Microsoft ...
11/13/2012, 5:22 pm from GuruFocus in Investing
Renowned value investor Seth Klarman just reported his third quarter
portfolio. He bought into one new position, Rovi Corp ( ROVI ), and added to
his positions in Novagold Resources, Inc.,... Read >>
The Baupost Group's Seth Klarman Adds to Stake of Idenix Pharmaceuticals
11/13/2012, 1:24 pm from GuruFocus in Investing
As of Nov. 9, Guru investor Seth Klarman of Boston-based hedge fund firm,
the Baupost Group, has reported to adding to his shares of company,
Idenix Phamaceuticals Inc. ( IDIX ), increasing... Read >>
Mid-Day Market Update: Markets Mixed; Weatherford International Falls Further
11/13/2012, 1:09 pm from Benzinga in Investing, Commodities, Earnings, Economy, International
Midway through trading Tuesday, the Dow traded up 0.19 percent
to 12,839.64 while the NASDAQ fell 0.21 percent to 2,8998.17 The
S&P also rose, increasing 0.22 percent to 1,383.07. Top... Read >>